A Comparison of the Effect of Intermittent and Continuous Infusion of Meropenem on the Prevalence of Nausea in Pediatric Cystic Fibrosis Patients

Authors

Marissa Cushing, Cedarville UniversityFollow
Juanita A. Draime, Cedarville UniversityFollow
Bao-Ngoc Ho, Cedarville UniversityFollow
Jordan Nicholls, Cedarville UniversityFollow
Bethany Sibbitt, Cedarville UniversityFollow
Rebecca Widder, Cedarville UniversityFollow
Rebecca J. Gryka, Cedarville UniversityFollow
Denise S. Simpson, Cedarville UniversityFollow

Document Type

Poster Session

Publication Date

11-2012

Research Advisor(s)

Rebecca J. Gryka, Pharm.D., Ph.D.; Denise Simpson, Ph.D.

Keywords

Meropenem, nausea, pediatrics, cystic fibrosis

Abstract

Cystic Fibrosis (CF) is a genetic disease, leading to changes of membrane secretions causing obstruction of smaller airways. CF patients often develop pulmonary infections and require antibiotic treatment. Meropenem is a broad spectrum beta lactam that acts by lysing microbes through interfering with bacterial cell wall synthesis. Although a safe and effective treatment, data on pediatric patients is limited.

Recommended Citation

Cushing, Marissa; Draime, Juanita A.; Ho, Bao-Ngoc; Nicholls, Jordan; Sibbitt, Bethany; Widder, Rebecca; Gryka, Rebecca J.; and Simpson, Denise S., "A Comparison of the Effect of Intermittent and Continuous Infusion of Meropenem on the Prevalence of Nausea in Pediatric Cystic Fibrosis Patients" (2012). Pharmacy and Nursing Student Research and Evidence-Based Medicine Poster Session. 6.
https://digitalcommons.cedarville.edu/pharmacy_nursing_poster_session/6

Creative Commons License

This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License.